Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal pathogen cell wall components form a multilayered, dynamic exoskeleton surrounding fungal cells. The main polymers are β-1,3-glucan, chitin, and mannan, often cross-linked and attached to glycoproteins. The structural scaffold provides cell shape, integrity, and protection against environmental stresses and immune attack. Fungal cell wall elements are absent in human cells, making them attractive antifungal drug targets. Key enzymes involved in biosynthesis—such as β-D-glucan synthase and chitin synthase—are therapeutic targets. Clinical antifungals like echinocandins disrupt cell wall architecture, leading to cell lysis and death. Fungi may develop resistance through cell wall remodeling (e.g., increased chitin), underlining the importance of ongoing research into cell wall molecular biology, adaptations, and new drug targets.
Inhibition of β-1,3-glucan synthesis (echinocandins, ibrexafungerp) Inhibition of chitin synthesis (nikkomycin) Inhibition of GPI anchor biosynthesis (fosmanogepix) Disruption of adhesion (targeting cell wall surface proteins)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal pathogen cell wall component.